Archive for the ‘Austria’ Category
Thursday, April 7th, 2011
Generating quality late-phase evidence & educating key stakeholders on drug value
Conference Dates: June21-22nd, 2011
The roles of medical affairs and liaison have never before been so crucial to the success of pharmaceutical strategic and operational commercial objectives. Medical departments play a vital role in generating quality clinical and real-world data that payers and prescribers need to improve decision making when uncertainty is high. Technologies such as EDC on the trial-sponsor side and e-healthcare on the payer/provider side also offer opportunities to understand and treat disease in diverse patient populations, across all therapeutic areas. The medical affairs department is increasingly becoming central to the coordination of internal stakeholders with the needs of external stakeholders and achieving more client-centric business models. Clearly, the pharmaceutical industry’s traditional sales and marketing models and processes are no longer effective and medical teams are now required to largely fill the void. New ways to engage with tomorrow’s stakeholders are now required.
As payers are increasingly the “gatekeeper” in deciding if a health technology should be reimbursed at all, evidence generation to demonstrate cost-effective health outcomes has never before become so vital. However, best practice approaches have not been defined well and there is still much confusion as to the best way of designing and implementing such studies that can provide relatively unbiased information. Medical teams not only need to develop strong data, but also need to help educate KOLs and payers on the value of that data, especially for complex diseases.
Developing and providing expert medical insight can also deliver strategic direction, increase drug and disease understanding. With particular focus on relationships with payers, KOLs and prescribers, pharmacies and patient advocacy groups, and by working across a range of internal departments on projects there is the real possibility of leveraging this information to create a win-win: increase innovation, patient access and achieve improved budget-effective health outcomes.
- Understand how medical affairs are at the forefront of new pharmaceutical industry commercial models and what needs to be done to maximise success.
- Discover what are the most intelligent ways to engage with KOLs and other prescribers, payers, patient groups, pharmacies and tomorrow’s stakeholders.
- Benchmark with experts to find out what are best practices in late-phase research, especially observational studies, patient registries and investigator initiated studies.
- Discover how medical liaisons, in support of commercial teams, are crucial to the communication of effectiveness, safety and cost-effectiveness.
Who will benefit?
VPs, directors, managers of Medical Affairs, Medical Science Liaisons, Medical Education, Health Outcomes, & Economics, Medical Marketing, Lifecycle management, Product management, KOL & stakeholder engagement, Late Phase Clinical development, Field Sales, Medical Advisor
To request the full agenda please follow the link:
For Booking Information contact:
Tel: +421 232 660 382
Fax: +421 2 3301 0331
Thursday, May 20th, 2010
Bratislava is the premier address for meetings, seminars and conferences hosted on a highly professional level. The variably configurable seminar rooms and modern equipment make it possible to stage an event that reflects perfectly all of your ideas and wishes! A 333 mÂ² seminar area with four flexibly configurable rooms and state-of-the-art conference technology, offering space for as many as 230 people.
Located in the centre of Bratislava, Austria Trend Hotel Bratislava truly is an exceptional place for your stay.
It is just 65 km from Vienna Airport to Bratislava. There is a regularly scheduled bus service on the Vienna Airport – Bratislava route.Â The drive takes about 40 minutes.
Monday, February 1st, 2010
There is clearly an increasing need for more innovative pricing and reimbursement agreements to help to balance the often conflicting objectives of pharmaceutical and medical technology manufacturers, payers, health technology assessors (HTA), physicians and patients. The industry faces a sustained increase in the cost of healthcare and an ever-increasing range of expensive drugs and technologies available as potential therapies.
Clearly, difficult choices need to be made by payers and HTAs about which products receive funding from increasingly restricted healthcare budgets, especially with often insufficient clinical and real-life evidence available. In terms of innovative agreements, more manufacturers, in more countries, are proposing risk-sharing and value-based schemes more often.
NextLevel Pharma has organized a unique meeting that will be focused purely on risk-sharing and value-based pricing schemes and will provide experts theories and practical case studies of successful models.
Understand the opportunities, obstacles and challenges in designing and implementing innovative agreements.
Find out when risk-sharing & value-based agreements are required and how they can be designed to satisfy all stakeholders to gain market access.
Understand whether or not the turbulent macroeconomic environment will increase payer motivation for flexible agreements.
Obtain the best and most focused picture of risk-sharing and value-based pricing models today.
Learn how drug effectiveness is being demonstrated in different regions.
Understand the best ways to communicate value and achieve maximum patient and market access.
Hear the perspectives of all stakeholder groups: Payers, regulators, insurers, health economists and the pharmaceutical industry.
Discover how payers are evaluating conditional reimbursement agreements.
Who should attend?
Vice-Presidents, Directors, Managers involved in:
Pricing & Reimbursement,
Health Economics & Outcomes,
Government & Stakeholder Relations,
Marketing & Commercial,
Therapy Area Heads,
Business Unit Heads
Solution providers & consultants:
Independent Academics, Health Economists, Senior Doctors, & Patient Representatives.
To request the full agenda please follow the link:
2nd Annual Pharmaceutical Risk-Sharing & Value-Based Pricing & Reimbursement Models
For Booking Information contact:
Tel: +421 232 660 382
Fax: +421 232 660 397
Sunday, May 31st, 2009
|If you are unable to read this email, view the online version here http://informa.msgfocus.com/q/1MAkBGemLIiyFH/wv
South Australian Future Energy Conference
17th – 18th August, Hilton Adelaide
South Australian Energy News
Oil & gas production in the Cooper Eromanga Basin received another large boost last week, with the announcement by Beach Petroleum and Cooper Energy of production coming online from the Perlubie-1 well at 3000 barrels of oil per day.
At the South Australia Future Energy Conference you will hear the latest drilling and exploration updates of Beach Petroleum from Reg Nelson, Managing Director. With another six wells to be drilled back to back, over a three month period this presentation will be highly anticipated.
Strike Oil has been granted a new exploration licence to explore coal seam gas in the Cooper Basin, South Australia. Simon Ashton, Managing Director of Strike Oil will give delegates strategic insights into the significant energy projects in Strike Oil’s portfolio at the South Australia Future Energy Conference.
Save up to $400 with the early booking discount – available until 1st June 2009. Book your place online.
Or, contact our customer service team on:
Phone: (+61 2) 9080 4307
At the South Australia Future Energy conference you will also hear from senior executives and experts including:
The Hon. Patrick Conlon, Minister for Energy, South Australia
Barry Goldstein, Director, PIRSA
Tino Guglielmo, Managing Director, Victoria Petroleum
Philip Kelso, Chief Executive Officer, Bounty Oil & Gas
Ashley Kellett, President, Australian Pipeline Industry Association APIA
John Heugh, Managing Director, Central Petroleum
Merrill Gray, Executive Director, Syngas
Chris Schrape, Managing Director, Altona Resources
Greg Allen, Chief Operating Officer, Carnegie Corporation
Michael Fielden, Managing Director, Acquasol
Bertus de Graaf, Managing Director, Panax Geothermal
Gerry Grove-White, Managing Director, Geodynamics Ltd
Click here to see the full agenda and list of speakers.
|A limited number of sponsorship and exhibition opportunities are available.
Please contact Deen Haniff on (02) 9080 4357 or firstname.lastname@example.org to discuss how best to tailor this opportunity to your needs.
Other energy based conferences for your diary:
4TH ANNUAL HOT ROCK ENERGY CONFERENCE
4 – 5 June 2009 | Grand Hyatt Melbourne
DECENTRALISED ENERGY CONFERENCE
9 – 10 June 2009 | Sydney Harbour Marriott
3RD ANNUAL DEMAND RESPONSE & DSM CONFERENCE
18 â€“ 19 June 2009 | Bayview Eden Melbourne
Friday, February 13th, 2009
All the latest for hunters, anglers, off-road enthusiasts and nature lovers
Hunting association anniversaries
Varied programme of side events
VIENNA The 2007 edition of the Jaspowa & Fishery & Off-Road underlined the status of the show as the leading event for the catchment areas of Vienna, Lower Austria, Styria, Burgenland and the entire neighbouring Danube region, emphasised Director Johann Jungreithmair, CEO of Reed Exhibitions Messe Wien. This hunting and angling show features an off-road drivers section and takes place once every two years. The next edition of the show is scheduled to take place on the 13th â€“ 15th February 2009 at Messe Wien venue.
Yet again the Jaspowa & Fishery & Off-Road 2009 will be here with all the latest products and trends developed by the exhibiting companies, and another broad-based selection of side events for hunters, anglers and off-road vehicle enthusiasts. The Lower Austrian and Burgenland hunting associations will both be celebrating 60 years of existence at the Jaspowa in 2009.
Off-road test course
Off-road enthusiasts will also be able to enjoy the special cross country course set up between the halls to test 4×4 vehicles and quad bikes; as well as numerous competitions organized to test driving skills. All the big 4×4 manufacturers will be there to introduce their very latest models.
Three days packed with expo action
In response to exhibitor demand we decided to concentrate the Jaspowa & Fischerei & Off-Road 2009 over a three day period, instead of the original four, announced Gernot Blaikner, Head of Group Exhibitions for the organisers, Reed Exhibitions Messe Wien. Taking place once every two years, the Jaspowa & Fishery & Off-Road in Vienna has continuously grown over the past few years. The increased presence and interest from the neighbouring Danube Basin regions is a further reason for optimism. 12% of the visitors registered at the previous show came from outside Austria; the bulk of them from Hungary, followed by the Czech Republic and Slovakia. The Jaspowa & Fishery & Off-Road 2007 was attended by a total of 18,374 visitors. Around 200 exhibitors occupied two halls and a large outdoor area at Messe Wien.